Navigation Links
Anesiva Receives Positive Nasdaq Hearing Panel Determination for Continued Listing
Date:11/9/2009

SOUTH SAN FRANCISCO, Calif., Nov. 9 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV) today announced that on November 5, 2009, it received a letter from The NASDAQ Stock Market LLC ("Nasdaq") stating that the Nasdaq Hearing Panel has granted Anesiva's request for continued listing on The NASDAQ Global Market subject to the condition that Anesiva shall have completed on or before December 31, 2009, the proposed merger (the "Merger") contemplated by the Agreement and Plan of Merger, dated August 4, 2009, among Anesiva, Arca Acquisition Corporation ("Arca"), a wholly-owned subsidiary of Anesiva, Arcion Therapeutics, Inc. ("Arcion") and, with respect to Articles V and IX only of the agreement, each of the Arcion stockholders listed on Schedule I thereto.

On October 30, 2009, Anesiva announced that the Anesiva 2009 Annual Meeting of Stockholders will be held on December 3, 2009 at 9:00 a.m. PST at 400 Oyster Point, Suite 107A, South San Francisco, California. Stockholders of record at the close of business on October 9, 2009 will be eligible to vote at the 2009 Annual Meeting of Stockholders, at which the proposed Merger will be considered and voted upon. The definitive proxy statement for the 2009 Annual Meeting of Stockholders was mailed to stockholders on or about November 6, 2009.

About Anesiva

Anesiva seeks to be a leader in the development and commercialization of novel pharmaceutical products for pain management. Anesiva's lead product candidate is Adlea, a novel small molecule formulation of capsaicin that is currently in development for management of both acute and chronic pain. Adlea has been shown in clinical trials to provide extended pain relief after only a single administration in a variety of localized moderate-to-severe pain conditions.

Additional Information and Where to Find
'/>"/>

SOURCE Anesiva, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Anesiva Announces FDA Approval of Supplemental New Drug Application to Expand Zingo(TM) Indication
2. Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring
3. Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company
4. Anesiva Commences Phase 2 Trial of Adlea(TM) in Arthroscopic Shoulder Surgery
5. Anesiva Announces South Korea FDA Approval of Adlea(TM) Investigational New Drug Application
6. Anesiva Announces Publication of Phase 3 Zingo(TM) Data in the Journal Pediatrics
7. Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Total Knee Replacement
8. Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy
9. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
10. Anesiva Defines Regulatory Pathway for Adlea with FDA
11. Anesiva Initiates Phase 2 Trial with Adlea(TM) for Pain Relief Following Total Hip Replacement Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... YORK , Sept. 2, 2015   About ... the most common laboratory technologies that is used for ... antibodies in solution. ELISA test uses various types of ... phosphatases and the result is detected by photometry or ... the treatment of various infectious diseases such as HIV, ...
(Date:9/2/2015)... Pa. , Sept. 2, 2015 ... increases, diversifies revenue base with highly profitable specialty ... , Near-term growth potential with 11 product ... include Paragraph IV certifications  , Provides medium ... candidates in development, including eight controlled substances ...
(Date:9/2/2015)... Sept. 2, 2015   Physicians Rx Pharmacy ... has joined the organization as President and Chief Executive ... as President and Chief Executive Officer for Soleo Health ... Officer of Physicians Rx Pharmacy, be responsible for leading ... are extremely pleased to bring Gaston on as the ...
Breaking Medicine Technology:Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market 2015-2019 2Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market 2015-2019 3Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 2Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 3Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 4Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 5Lannett To Acquire Kremers Urban Pharmaceuticals For $1.23 Billion 6Gaston L. Bernstein Named President and CEO of Physicians Rx Pharmacy 2
(Date:9/3/2015)... ... September 03, 2015 , ... As ... increases for fully insured employer-sponsored health insurance plans, more employers are moving to ... to data released from the 2014 United Benefit Advisors (UBA) Health Plan Survey. ...
(Date:9/3/2015)... ... 2015 , ... Hunters Creek Retrievers is again honored to salute ... Lab Puppy. Celebrate Fall 2015 with unlimited Free Hugs and K9 Kisses from a ... and Christmas with an extra big smile. , This adorable trained Lab Pup ...
(Date:9/3/2015)... ... September 03, 2015 , ... “We wish to become ... the delicate life balance between work and leisure to the benefit of every ... CEO , A LifeMinder Plus® Emergency Care Document Set duly executed set ensures ...
(Date:9/3/2015)... ... September 03, 2015 , ... “Love in Tokyo” an independent romantic comedy ... and Amazon and will be released on DVD early next year, by ... Foreigner,” Itsuka, an actress and singer/songwriter, and Jason London, lead from “Dazed and Confused.” ...
(Date:9/3/2015)... Brea, CA (PRWEB) , ... September 03, 2015 ... ... Dental received a top review from Clinicians Report of Provo, Utah. The Clinicians ... conducted by a selected group of dentists located throughout the U.S. Whiter Image's ...
Breaking Medicine News(10 mins):Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 2Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 3Health News:Self-Funded Pharmacy Plans Becoming More Popular Among Large Employers 4Health News:Hunters Creek Retrievers Is Honored to Support the Lone Survivor Foundation with a Championship Trained Black Labrador Retriever Puppy 2Health News:Hunters Creek Retrievers Is Honored to Support the Lone Survivor Foundation with a Championship Trained Black Labrador Retriever Puppy 3Health News:LifeMinder Plus® Announces Emergency Care Document Set Giveaway for America 2Health News:LifeMinder Plus® Announces Emergency Care Document Set Giveaway for America 3Health News:The Romantic Comedy Film "Love in Tokyo" Has Been Released on ITunes, Google Play, and Amazon 2Health News:Whiter Image Products Get Positive Rating From The Clinicians Report 2
... a new approach to preventing colorectal cancer without ... Vanderbilt University Medical Center researchers report. , ... of Clinical Investigation , Raymond Harris, M.D., Ming-Zhi ... enzyme 11β-hydroxysteroid dehydrogenase type 2 (11βHSD2) either ...
... study finds an effect, but critics say meat offers important ... in red meat and in processed meat shorten life span ... stomach ulcers and an array of other conditions as well, ... fact, reducing meat consumption to the amount eaten by the ...
... MECHANICSBURG, Pa., March 23 Select Medical Corporation ("Select") ... ended December 31, 2008.For the fourth quarter ended December ... million compared to $518.0 million for the same quarter, ... $57.5 million compared to $41.7 million for the same ...
... scheduled at 5:00 PM Eastern Time today Corporate Developments ... new drug application (NDA) to the U.S. Food ... a July 30, 2009 Prescription Drug User Fee Act ... NDA- January 2009: Completed merger with Novacea, Inc. ...
... Challenges Common Medical PracticePHILADELPHIA, March 23 For ... visually examined newborn babies for the yellowish skin ... jaundice carried a greater risk of illness.The yellowness ... child that develops high levels of bilirubin has ...
... on Science, Not IdeologyWASHINGTON, March 23 Today, the ... York ruled that the Food and Drug Administration (FDA) ... dedicated emergency contraceptive product) based on age was "arbitrary ... faith decision-making." The court ordered the FDA to extend ...
Cached Medicine News:Health News:Licorice compound offers new cancer prevention strategy 2Health News:Licorice compound offers new cancer prevention strategy 3Health News:Too Much Red Meat May Shorten Life Span 2Health News:Too Much Red Meat May Shorten Life Span 3Health News:Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2008 2Health News:Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2008 3Health News:Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2008 4Health News:Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2008 5Health News:Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2008 6Health News:Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2008 7Health News:Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2008 8Health News:Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2008 9Health News:Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2008 10Health News:Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2008 11Health News:Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2008 12Health News:Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2008 13Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 2Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 3Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 4Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 5Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 6Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 7Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 8Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 9Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 10Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 11Health News:Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results 12Health News:Don't Rely on Jaundiced Eye for Assessing Newborns 2Health News:Don't Rely on Jaundiced Eye for Assessing Newborns 3Health News:Don't Rely on Jaundiced Eye for Assessing Newborns 4Health News:Advocates for Youth Applauds Court Ruling on EC Age Restriction 2
... is a complete practice and business ... optometrists, opticians and ophthalmologists- It is ... seeking a graphically rich and intuitive ... of solid features and functionality- The ...
... 70 hematology system delivers a ... Designed for speed and accuracy, ... cost-effectiveness with impressive productivity. The ... on its own or twinned ...
The SE-9500 automated hematology analyzerprovides accurate and precise CBC result including a fully automated WBC 5-part differential, and comprehensive test results for enhanced screening ability....
The SE-9000 automated hematology analyzer provides accurate and precise CBC result including a fully automated WBC 5-part differential, and comprehensive test results for enhanced screening ability....
Medicine Products: